Neuromuscular blocking agents
US5453510A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 10, 1992 |
| Grant date | Sep 26, 1995 |
| Priority date | — |
| Expiry date | Jul 10, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
1R-cis,1'R-cis isomer of a 2',2'-(3,11-dioxo-4,10-dioxatridecylene)-bis(1,2,3,4-tetrahydro-6, 7-dimethoxy-2-methyl-1-veratrylisoquinolium) said, substantially free from other geometrical and optical isomers thereof. The 1R-cis,1'R-cis isomer has been found to have an advantageous combination of pharmacological properties, notably greater neuromuscular blocking potency, weaker histamine-releasing potency, and at equivalent levels of neuromuscular blockade, fewer potential adverse effects on the autonomic nervous system (sympathetic and parasympathetic blockage), in comparison with the known mixture of geometrical and optical isomers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.